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The drive for optimal healthcare of pregnant women is one of 
the bases of the health system in South Africa (SA). Part of this 
responsibility concerns care of pregnant women who are living with 
HIV. Prevention of mother-to-child transmission (PMTCT) of HIV 
concerns reducing transmission of HIV to the fetus and infant.
The vast majority of pregnant women in KwaZulu-Natal (KZN) 
Province receive their antenatal care in primary healthcare (PHC) 
clinics, both fixed and mobile. In the PHC clinics, nurse-clinicians 
do almost all the work of screening pregnant women for HIV at 
their first antenatal or booking visit. The nurse-clinicians then take 
the baseline bloods that relate to pregnancy and HIV. HIV-positive 
pregnant women start taking antiretrovirals (ARVs) the same day. 
This booking visit is a complex process, in the course of which the 
nurse-clinician has to consider several variables, obstetric, HIV-
related and more. Often nurse-clinicians with relatively little ARV 
training and support have to undertake the task of ARV management 
of pregnant women.
The excellent design of the SA maternity case record (MCR) 
assists in this complex booking process by providing a well-laid-out 
document for antenatal care, particularly on pages 2 and 3.[1] Page 2 
contains fields for the booking visit. Page 3 contains the symphysis-
fundal height graph that allows monitoring of fetal growth, together 
with blood pressure, urinalysis, haemoglobin, etc. The MCR is a 
patient-held record and therefore bridges the communication gap 
antenatally between PHC clinic and hospital. Women are referred 
to a hospital-based high-risk antenatal clinic as necessary. Most 
women in KZN and SA deliver their babies in hospital labour wards. 
Postnatally, the communication gap between the hospital and the 
PHC clinic is bridged by the discharge summary, which is printed on 
pages 31 and 33 of the MCR. The top copy of the summary is taken 
home by the new mother. This summary provides vital information 
for the clinicians at primary care level who follow up the mother in 
the puerperium, as well as the new baby.
However, the SA MCR was not able to keep pace with recent 
advances in the national ARV programme. The MCR had a dedicated 
space only for the CD4 count on page 2, with no dedicated space 
for HIV viral load and serum creatinine results. Paper copies of 
the laboratory results were often stapled to the back of the MCR. 
According to the protocol in the national ARV guidelines at the 
time,[2] blood tests were to be done as follows: 
• At booking, a CD4 count was taken on all HIV-positive pregnant 
women. If the CD4 count was <100 cells/µL, disseminated 
cryptococcosis should be considered; a low CD4 count may 
also indicate the need for cotrimoxazole prophylaxis. Serum 
creatinine should have been taken at booking to check renal 
function, as tenofovir (potentially nephrotoxic) is part of the 
fixed-dose combinations (FDCs) of ARVs that most pregnant 
women take. The CD4 and creatinine results should have been 
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Background. The correct antiretroviral (ARV) management of HIV-positive pregnant women can be complex, with many variables to 
consider. uMgungundlovu District Management in KwaZulu-Natal (KZN) Province, South Africa, suspected that the taking and retrieval 
of blood tests relating to ARV management in pregnancy could be improved. An antenatal ARV tracking form was therefore designed: a 
dedicated page on which to write all the ARV-related blood results and remind clinicians to take the correct bloods at the appropriate time. 
The form was photocopied and distributed to all antenatal clinics throughout uMgungundlovu District.
Objectives. To audit uptake of use of the tracking form by antenatal clinicians, and to audit quality of care – did using the tracking form 
prompt the correct bloods to be taken and retrieved at the right time, and with correct antiretroviral management and outcome?
Methods. Data were collected by retrospective chart review of maternity case records of women who delivered at Northdale District 
Hospital, uMgungundlovu District, KZN. We determined compliance with use of the tracking form in the maternity case records of all HIV-
positive women delivering at the hospital, and assessed quality of care by scoring 100 records of women with a tracking form in comparison 
with 100 records of women without one.
Results. District-wide uptake of use of the tracking form in maternity case records was 95%. Quality of care showed a statistically significant 
improvement in women with a tracking form present in their maternity case record: nearly 80% of those with a form were correctly managed 
at the booking visit, v. <20% of those without one (79% v. 19%; p<0.001). The differences in quality of care persisted at 3 and 6 months after 
booking. In terms of outcome, HIV viral load was suppressed at the time of delivery in 86% of women with a tracking form v. 65% of those 
without, and 5% of women with a tracking form had an unknown viral load v. 21% of those without.
Conclusions. Uptake of use of the tracking form increased markedly after implementation. Use of the form significantly improved the taking 
and retrieval of blood tests and the management of ARVs. The form has since been printed as part of the new maternity case records in KZN.
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reviewed the following week. A viral load 
should have been taken at booking if a 
woman was already taking ARVs before 
the pregnancy.
• At 3 months after booking, an ARV-naive 
pregnant woman should have had a viral 
load and creatinine taken.
• At 6 months after booking, all pregnant 
women on ARVs should have had 
a viral load and creatinine taken. The 
maternal HIV viral load should have been 
suppressed (<1 000 copies/mL) before 
or by the time of delivery. The 3- and 
6-month blood results were reviewed at 
the next antenatal visit.
Having a known and suppressed viral load 
was therefore the ideal situation for the 
woman to be in at the time of delivery. Many 
pregnant women were delivering without 
the hospital knowing their viral load. The 
hospital may have taken a viral load at time 
of delivery, but because the result takes a 
week to be available from the laboratory, 
it was not ready before the new mother 
was discharged and sent home. PHC clinics 
struggled to trace laboratory tests that were 
taken at the hospital.
The uMgungundlovu District Clinical 
Specialist Team (DCST) and District 
Manage ment were concerned about the 
taking and retrieval of blood tests relating to 
ARV management in pregnancy, suspecting 
that it could be improved. The clinicians in 
the DCST ‘provide clinical mentorship and 
guidance to health facilities to improve their 
ability to provide effective maternal, neonatal 
and child health services’.[3] Improvements 
required were that the correct blood test 
needed to be taken, and at the appropriate 
time in relation to ARV initiation. The 
presence of a laboratory printout of the blood 
results in the MCR did not guarantee that the 
correct management was being undertaken.
The antenatal ARV 
tracking form
A group of nurses and a doctor from the 
DCST and Northdale Hospital met in 2015 
to find a solution to the above problem 
(other resources examined included the 
PMTCT checklist that was used in Western 
Cape Province). Northdale is a busy district 
hospital in Pietermaritzburg, and delivered 
5 739 women in 2017. The group designed 
an antenatal ARV tracking form (Fig. 1) for 
easy use by nurse- and medical clinicians in 
the management of HIV-positive pregnant 
women. The tracking form was used at all 
PHC clinics and community health centres 
(CHCs) and in the four general hospitals 
in uMgungundlovu District. The form was 
designed to be stapled onto page 4 of the 
MCR, which was the first blank writing page. 
The information was therefore prominently 
placed in the MCR and the form was easy to 
read and write on.
The aims of introducing the ARV 
tracking form were two-fold: (i) to provide a 
dedicated and easy-to-use page on which to 
write all the required blood tests relating to 
ARVs in pregnancy; and (ii) for the form to 
serve as a reminder to do the correct bloods 
at the appropriate times: at booking, and at 3 
and 6 months.
The ARV tracking form was introduced in 
August 2015 along with orientation sessions 
at perinatal mortality meetings and antenatal 
clinics throughout the district. An audit of 
this pilot phase of use of the tracking form 
was done in September 2016. During this 
month, 154 MCRs of HIV-positive pregnant 
women were checked in the postnatal ward at 
Northdale Hospital. Only 50% of MCRs had 
a tracking form. A more intensive campaign 
was therefore launched to ensure that all 
clinicians working in antenatal clinics used 
a tracking form in the MCR of every HIV-
positive pregnant woman.
Anecdotally, the tracking form appeared 
to have been very effective in reminding 
clinicians to take and record the correct 
bloods  at the correct time. However, a 
formal audit was required. The question 
was asked: ‘Has the use of the ARV 
tracking form improved the monitoring 
of the relevant blood  tests, leading to the 
correct ARV manage ment of HIV-positive 
pregnant women?’ In 2017, we obtained 
ethical clearance for the research from 
uMgungundlovu Health Ethics Review 
Board and with kind permission from 
Northdale Hospital.
Fig. 1. The antenatal antiretroviral tracking form.
Figure 1: The Antenatal ARV Tracking Form 
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Further background to the ARV tracking form
The HIV prevalence among pregnant women in uMgungundlovu in 
2017 was >40%.[4] The PHC nurse-clinicians were therefore working 
in a setting with a high prevalence of HIV. Quality of care and ARV 
management mainly related to the correct taking, retrieval and 
interpretation of the blood tests. The term ‘management’ includes 
dispensing the actual ARV pills by the clinician; however, this had 
become very simple, because a single daily FDC pill was used for most 
pregnant women. At the time of the research, clinicians were using 
the 2015 National Consolidated Guidelines.[2] The guidelines were 
clear and simple to follow for the majority of pregnant women, who 
were treated with FDC ARVs, usually TEE (tenofovir, emtricitabine, 
efavirenz). There was also an application for smartphones and 
electronic tablets, so that the guidelines can easily be referenced in the 
consulting room.[5] A recent review article supported the effectiveness 
of the 2015 ARV regimen for pregnant women.[6] Recent updates 
of the ARV and PMTCT guidelines were released in 2019.[7,8] The 
new guidelines included some changes to the timing of blood tests, 
especially an HIV viral load at the time of delivery. Dolutegravir, an 
integrase inhibitor, was added to first-line ARV regimens, including 
pregnant women from 8 weeks’ gestation. uMgungundlovu District 
started using dolutegravir in December 2019, mainly in an FDC called 
TLD (tenofovir, lamivudine and dolutegravir).
The National Guidelines for Maternity Care,[9] which are widely 
used in PHC clinics, CHCs and hospitals, clearly explain the necessary 
steps to be taken when starting a pregnant woman on ARVs. In SA, 
midwives initiate ARVs in the majority of the low-risk pregnant 
women, and doctors are involved in the management of women who 
have obstetric, renal or mental health problems or virological failure. 
Stinson et al.[10] commented that the FDCs have made ARV therapy 
easier for both clinicians and (pregnant) women.[10] The adaptation of 
adherence counselling led to shorter sessions that allow for same-day 
initiation, with increased post-initiation counselling being piloted in 
Khayelitsha, Cape Town. Despite the increased workload, midwives 
felt empowered and were passionate about their new role: ‘Nowadays 
we manage their pregnancy and we also manage their HIV.’ Stinson 
went on to comment: ‘The new challenge is to retain women 
on ART [antiretroviral therapy] and achieve sustained virological 
suppression.’ The tracking form was designed to track the HIV viral 
load, at least during the antenatal course.
The MCR at the time of the research (2017) was a relatively new 
National Department of Health document, released in 2010.[1] Sibiya 
et al.[11] described the perceptions of nurses working in eThekwini 
District in KZN regarding the new MCR. There were several 
negative conclusions, including that ‘They [the PHC nurses] stated 
that the card is not user-friendly and does not provide spaces for 
recording relevant elements for Basic Antenatal Care and PMTCT.’ 
Ngxongo et al.[12] examined the application of the basic antenatal care 
principles in the MCR, also in eThekwini District. They wrote: ‘It is 
recommended that relevant policies, service delivery guidelines, and 
protocols should be available in all PHC clinics that provide ANC 
services and all staff members and managers should be trained to use 
these documents to ensure safe and standardised practice. Records 
should be designed so that relevant aspects of the implementation 
of policies required are recorded. This will facilitate auditing of the 
implementation of policies.’ The antenatal ARV tracking form was 
designed to achieve this recommendation.
Objectives
The first objective of the research was to audit uptake of use of the 
antenatal ARV tracking form by antenatal clinicians. The second 
objective was to audit the quality of care – did use of the tracking 
form prompt the correct bloods to be taken and retrieved at the 
correct time, and with correct ARV management and outcome?
Methods
The data for the research audit were retrieved from the MCRs of HIV-
positive pregnant women who either delivered or were managed in 
the postpartum ward at Northdale Hospital and had been discharged 
home. The research design was a retrospective chart review.
The MCRs of HIV-positive patients were audited as follows: 
• Uptake of use of the antenatal ARV tracking form by antenatal 
clinicians was measured. The MCRs of all HIV-positive patients 
who delivered at Northdale Hospital during December 2017 were 
checked for the presence and use of a tracking form.
• Quality of care was then determined by checking 100 patients’ 
MCRs with a tracking form and 100 patients’ MCRs without a 
form. The 100 MCRs with a tracking form were identified by 
working back in time from 31 December, using the date of delivery. 
The 100 MCRs without a form were identified from the whole of 
2017 and January 2018. A longer time period of data collection 
had to be used because of the scarcity of MCRs of HIV-positive 
women without a tracking form in their MCR. (Based on the HIV 
prevalence of 40% and the fact that only 5% of MCRs did not have 
a tracking form, few MCRs were suitable.)
A 1-page tracking form audit tool (Fig. 2) was developed to capture 
the results from the MCR of each woman. The following data were 
audited:
• general information about the pregnancy, e.g. gestation at 
booking
• CD4, creatinine and possibly viral load at booking
• viral load and creatinine after 3 months if the woman was ARV naive
• viral load and creatinine after 6 months
• retrieval, recording and interpretation of the blood results at the 
next scheduled antenatal visit
• correctness of ARV management at booking, 3 months and 6 
months 
• HIV viral suppression at the time of delivery.
Exclusions
The following women were excluded from the study: (i) women who 
started their ARVs <1 month before delivery; (ii) ‘unbooked’ women 
who had not attended antenatal care; (iii) women who attended 
antenatal care in other southern African countries, as these countries 
may have had a different PMTCT programme; and (iv) women who 
delivered babies at <28 weeks’ gestation by dates and where there was 
no evidence of life at delivery.
Statistical analysis
The data in the 200 audit tools were captured onto Excel spreadsheets, 
version 2010 (Microsoft, USA). We then analysed baseline 
characteristics of the women by univariate comparisons. We used 
the χ2 test for categorical variables, the one-way test for continuous 
variables, and the Kruskal-Wallis test for non-normal continuous 
variables (weeks’ gestation at delivery).[13,14] Statistical analysis was 
done with the R statistical computing environment, version 3.6.0 
(R Foundation for Statistical Computing, Austria) and the package 
‘tableone’.[15,16]
Results
Uptake of tracking form use
Of the 152 HIV-positive patients who delivered at Northdale Hospital 
during December 2017, 144 had an antenatal ARV tracking form 
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inserted and utilised in their MCR (95% 
compliance).
Baseline characteristics of the 
patients (Table 1)
The baseline characteristics of the 100 
women with a tracking form in their 
MCR and the 100 women without one 
showed no significant differences in 
maternal age, gestation at booking or 
delivery, infant birthweight, or the timing 
of ARV initiation before or during their 
pregnancies. Of the women without a 
tracking form in their MCR, 62% had 
booked in uMgungundlovu: conversely, 
38% had booked in another district in 
KZN or SA and yet had delivered at 
Northdale Hospital.
Tracking form placement in the 
MCR (Table 2)
Of the 100 tracking forms that were present 
in the MCR, 65 had been stapled onto page 
4. Most of the 35 tracking forms that were 
not stapled onto page 4 were stapled to 
the inside front cover of the MCR: These 
tracking forms quickly became covered over 
by other pregnancy-related papers such 
as health messages, fetal kick charts and 
cardiotocograph recordings. In the subgroup 
of women with a tracking form, we checked 
for differences between those with the form 
correctly placed on page 4 of the MCR v. 
those with the form placed elsewhere in 
the MCR. Baseline characteristics between 
those women with tracking forms on page 
4 v. a form placed in other parts of the MCR 
showed no significant differences in maternal 
age, gestation at booking or delivery, infant 
birthweight, or the timing of ARV initiation 
before or during the pregnancy.
Quality of care (Table 3)
Outcomes between patients with and without 
a tracking form present in the MCR were 
statistically different by univariate analysis. 
Nearly 80% of women with a tracking form 
in their MCR were correctly managed at the 
booking visit, v. <20% of those without the 
form (79% v. 19%; p<0.001). The differences 
in quality of care persisted at 3 and 6 months 
after booking.
Women without a tracking form in their 
MCR were also more likely to have errors 
in ARV management (92% v. 38%; p<0.001) 
and renal function monitoring (86% v. 32%; 
p<0.001).
Most notably, tracking form use was 
significantly associated with having a sup-
pressed maternal HIV viral load at delivery 
(86% v. 65%; p=0.001). The key results are 
summarised graphically in Fig. 3.
Tracking form placement in the 
MCR (Table 4)
When we looked at the effects of correct 
placement of the tracking form on page 4 of 
the MCR in the subgroup of women with a 
form, correct placement was associated with 
fewer errors in ARV management (29% v. 
54%; p=0.025) and renal monitoring (21% 
v. 51%; p=0.005). However, there was no 
significant difference in maternal HIV viral 
load suppression at delivery (88% v. 83%; 
p=0.812).
Qualitative analysis of the MCRs
Some issues of quality were noted during 
the analysis of the 200 MCRs.
The recommended follow-up dates were 
not always adhered to by clinicians or patients. 
There were several instances of bloods being 
taken, but the results not being retrieved. 
The following systems issues were identified 
from the clinicians’ notes: (i)  paper copies 
of the laboratory results were not received 
back at the clinic; (ii) clinic telephones were 
out of order so clinicians could not phone 
the laboratory for blood results (a very time-
consuming process anyway); (iii) clinicians 
could not access the blood results from the 
database on the National Health Laboratory 
Service (NHLS) Labtrak system because 
the clinic did not have intranet access, a 
Labtrak password or Labtrak access via their 
smartphone; (iv)  mobile clinics could not 
review patients 1 week after booking because 
the mobile clinic only visited that point once 
Figure 2: Tracking Form Audit Tool 
Fig. 2. Antiretroviral tracking form audit tool.
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a month; and (v) there were incidences when blood results were not 
ready on time owing to rejection by the NHLS electronic gatekeeping 
(EGK) system. Once this happened, the nurse-clinicians working in 
the antenatal clinics struggled to catch up with the correct bloods. 
(The NHLS has since introduced a special EGK code for the PMTCT 
situation that will obviate these delays.) The audit of the 200 MCRs 
showed that improvements could be made in the completion of the 
discharge summaries. During the working week, the regular PMTCT 
midwife included the pertinent results and comments for good ARV-
related follow-up at the PHC clinic. When the PMTCT midwife was 
not on duty, the quality of ARV-related information in the discharge 
summary was poorer.
Discussion
Uptake of tracking form use in antenatal clinics
Utilisation of the antenatal ARV tracking form in the MCRs had 
improved in uMgungundlovu District since implementation in 
August 2015. Uptake in use increased from 50% to 95% in the 
15  months between audits. This good level of compliance reflected 
well on the clinicians working in the antenatal clinics. Use of the 
tracking form had been actively promoted, but such good compliance 
may indicate that the form was actually assisting clinicians in their 
work in the antenatal clinics.
Baseline characteristics of the pregnant patients
There were no significant differences in baseline characteristics 
between women with or without a tracking form in their MCR. 
Similarly, there were no significant differences between those with the 
form placed correctly on page 4 or not. These findings suggest a lack of 
bias in those women who had a tracking form. In the group of pregnant 
women with a tracking form in their MCR, it followed that 100% 
Table 1. Baseline characteristics of the patients included in the audit
Indicator Tracking form present Tracking form missing p-value 
N (total number of records) 100 100
Maternal age (years), mean (SD) 28.88 (5.97) 27.63 (6.13) 0.146
Gestation at booking (weeks), mean (SD) 16.77 (7.02) 18.55 (8.23) 0.103
Booked before 20 weeks’ gestation, n (%) 65 (65.0) 56 (57.1)* 0.323
Weeks’ gestation at delivery, median (IQR) 39.0 (38.0 - 40.0) 40.0 (37.0 - 40.0) 0.688
Birthweight (g), mean (SD) 3 030 (42) 2 980 (52) 0.439
Low-birthweight babies (<2 500 g), n (%) 9 (9.0) 13 (13.0) 0.498
ARVs initiated during this pregnancy, n (%) 36 (36.0) 40 (40.0) 0.662
ARVs initiated before this pregnancy, n (%) 64 (64.0) 60 (60.0) 0.662
Booked at an uMgungundlovu District health facility, n (%) 100 (100) 62 (62.0) <0.001
SD = standard deviation; IQR = interquartile range; ARVs = antiretrovirals; MCR = maternity case record.
*The denominator was 98, because the gestation at booking was not available in two MCRs.
Table 2. Tracking form placement in patients with a tracking form in their MCR
Tracking form on p. 4 Tracking form not on p. 4 p-value
N (total number of records) 65 35
Maternal age (years), mean (SD) 28.43 (6.28) 29.71 (5.33) 0.307
Gestation at booking (weeks), mean (SD) 16.37 (7.18) 17.51 (6.73) 0.439
Booked before 20 weeks’ gestation, n (%) 43 (66.2) 22 (62.9) 0.912
Weeks’ gestation at delivery, median (IQR) 39.0 (38.0 - 40.0) 39.0 (38.0 - 40.0) 0.503
Birthweight (g), mean (SD) 3 020 (38) 3 040 (49) 0.837
Low-birthweight babies (<2 500 g), n (%) 5 (7.7) 4 (11.4) 0.798
ARVs initiated during this pregnancy, n (%) 27 (41.5) 9 (25.7) 0.176
ARVs initiated before this pregnancy, n (%) 38 (58.5) 26 (74.3) 0.176
Booked at an uMgungundlovu District health facility, n (%) 65 (100.0) 35 (100.0) n/a
























































































Fig. 3. Stratified outcomes: Quality of care in patients with and without a 
tracking form in their MCR. (MCR = maternity case record; ARV = anti-
retroviral.)
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booked at an antenatal clinic in uMgungundlovu District (at that time, 
uMgungundlovu was the only district using the tracking form). Of the 
group of women without a tracking form, 38% had booked in another 
district or province in SA. It is known that a significant percentage of 
patients in KZN are geographically mobile.[17] The use of the patient-
held MCR does assist the continuity of information.
Quality of care
Our analysis showed a clear improvement in correctness of care at 
booking and at 3 and 6 months of pregnant women with a tracking 
form present in their MCR, in comparison with women without a 
form. There was a significant improvement in maternal HIV viral 
load suppression at the time of delivery in women with a tracking 
form. Several factors (e.g. individual, social, pharmacological and 
financial) contribute to HIV viral suppression in pregnant women. 
However, clinicians should optimise quality of healthcare, which 
is but one of these factors. The use of tracking forms did assist the 
clinicians in improving quality of healthcare. It was a concern that 
23 of the 200 women’s viral loads (11.5%) were unsuppressed, in 
spite of receiving antenatal care from clinicians at both PHC clinics 
and hospitals. A key advantage of the use of a tracking form was the 
reduction of unknown viral load results (n=5 v. n=21). A known 
viral load was important at the time of delivery, because the infant’s 
PMTCT treatment differed if the viral load was >1 000 copies/mL. 
A  viral load could be taken at the hospital, but it may have been 
difficult to trace the result at primary care level, as not all PHC clinics 
had access to the NHLS Labtrak system.
Placement of the tracking form in the MCR
Ideally the tracking form should have been stapled onto page 4 
of the MCR. Of the 100 tracking forms, 35 were stapled in other 
places in the MCR, especially to the inside front cover. This made it 
very difficult to find, update, refer to or even remember to use the 
tracking form.
Significant errors in care
The number of significant errors in general ARV care was lower 
in women whose MCR had a tracking form than in women 
without a form. Many of the significant errors were related to the 
taking, checking and interpretation of blood results. The number of 
significant errors with renal function monitoring was also lower in 
women with a tracking form present in their MCR. In pregnancy, the 
serum creatinine level is used to measure renal function in the clinic 
setting, the cut-off being 85 mmol/L.
Antenatal tracking form and discharge summaries
Antenatally, the tracking form has helped bridge the HIV information 
gap that exists between primary care and hospital level. Postnatally, 
the information gap from hospital level back to PHC clinic should be 
bridged by the discharge summary. Discharge summaries could have 
Table 4. Stratified outcomes based on tracking form placement in those patients with a form in their MCR
Tracking form on p. 4 Tracking form not on p. 4 p-value
N (total number of records) 65 35
Correct care at booking, n (%) 54 (83.1) 25 (71.4) 0.268
Correct care at 3 months, n (%) 26 (70.3) 6 (40.0) 0.086
Correct care at 6 months, n (%) 17 (77.3) 6 (46.2) 0.132
Significant errors in ARV management, n (%) 19 (29.2) 19 (54.3) 0.025
Significant errors in renal monitoring, n (%) 14 (21.5) 18 (51.4) 0.005
Maternal HIV viral load suppressed (<1 000 copies/ mL) at delivery, n (%) 0.812
No 5 (7.7) 4 (11.4)
Yes 57 (87.7) 29 (82.9)
Unknown 3 (4.6) 2 (5.7)
MCR = maternity case record; ARV = antiretroviral.
Table 3. Stratified outcomes: Quality of care in patients with and without a tracking form in their MCR
Tracking form present Tracking form missing p-value 
N (total number of records) 100 100
Correct care* at booking, n (%) 79 (79.0) 19 (19.4)† <0.001
Correct care* at 3 months, n (%) 32 (61.5)‡ 11 (19.0)‡ <0.001
Correct care* at 6 months, n (%) 23 (65.7)‡ 6 (17.1)‡ <0.001
Significant errors§ in ARV management, n (%) 38 (38.0) 92 (92.0) <0.001
Significant errors in renal monitoring, n (%) 32 (32.0) 86 (86.0) <0.001
Maternal HIV viral load suppressed (<1 000 copies/mL) at delivery, n (%) 0.001
No 9 (9.0) 14 (14.0)
Yes 86 (86.0) 65 (65.0)
Unknown 5 (5.0) 21 (21.0)
MCR = maternity case record; ARV = antiretroviral.
*Correct bloods taken and retrieved at the correct time, and correct ARV management and outcome.
†MCRs missing a tracking form: 98 of 100 were analysed at booking. The two gaps in ARV-related bloods were as follows: one woman seroconverted during pregnancy, and the private doctor did 
not write the blood results in the MCR; and one MCR was lost by a patient who had social problems, so another MCR was issued.
‡The denominators for women at 3 and 6 months decreased from booking for the following reasons: some women delivered before the 3- or 6-month bloods became due; and women already on 
ARVs did not require bloods to be taken at 3 months if their viral load was suppressed at booking.
§Significant errors included the following examples: blood tests not taken at the correct time; blood results not retrieved; blood results such as high creatinine not acted upon; high viral load not 
managed correctly or timeously; patient given an incorrect follow-up date, etc.
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been more clearly and accurately written. Better information about 
HIV and postnatal ARV care could be integrated into a new format 
of the discharge summary.
Study limitations
The 100 MCRs with a tracking form were sampled in December 2017. 
The 100 MCRs without a tracking form required a longer period of 
sampling because of the scarcity of usable MCRs. There was overlap 
of the time periods, but the periods did differ.
Conclusions
The use of the antenatal ARV tracking form met the two aims. Firstly, 
the form provided a dedicated, easy-to-use page on which to write all 
ARV-related blood tests in pregnancy – the form was well utilised by 
the antenatal clinicians. Secondly, the form provided a reminder to 
clinicians to do the correct bloods at the appropriate time. The use 
of the tracking form in the MCRs improved the taking and retrieval 
of the relevant blood tests, leading to significantly better ARV 
management of HIV-positive pregnant women.
Recommendations 
• Some type of antenatal ARV tracking form should be incorporated 
in the future design of the MCR. The KZN Department of Health 
has adopted the use of the tracking form, and from 2019 all newly 
printed MCRs have a tracking form printed on page 4.
• Minor modifications may have to be made to the tracking form so 
that it aligns with the new 2019 PMTCT guidelines.[11]
• To strengthen the postnatal link between hospital level and 
follow-up of ARV management and blood results at PHC level, 
better information about HIV and postnatal ARV care could be 
integrated into the format of the discharge summary in the future 
design of the MCR.
• All fixed and mobile PHC clinics should have access to laboratory 
results on NHLS Labtrak, either by computer or smartphone. This 
will facilitate the tracing of the important laboratory tests relating 
to HIV in pregnancy: HIV viral load, CD4, serum creatinine, Xpert 
for tuberculosis, and HIV polymerase chain reaction in babies.
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